-
2
-
-
34748822439
-
Cecal adenocarcinoma with prominent rhabdoid feature: Report of a case with immunohistochemical, ultrastructural, and molecular analyses
-
DOI 10.1177/1066896907302418
-
Kono T, Imai Y, Imura J, et al. Cecal adenocarcinoma with prominent rhabdoid feature: report of a case with immunohistochemical, ultrastructural, and molecular analyses. Int J Surg Pathol. 2007 ; 15: 414-420 (Pubitemid 47476075)
-
(2007)
International Journal of Surgical Pathology
, vol.15
, Issue.4
, pp. 414-420
-
-
Kono, T.1
Imai, Y.2
Imura, J.3
Ono, Y.4
Hagiwara, S.5
Taira, K.6
Fujita, M.7
Tsubaki, M.8
Sunagawa, M.9
Fujimori, T.10
-
3
-
-
0029923967
-
Malignant rhabdoid tumor of the colon: Report of a case with molecular analysis
-
Marcus VA, Viloria J, Owen D, Tsao MS. Malignant rhabdoid tumor of the colon: report of a case with molecular analysis. Dis Colon Rectum. 1996 ; 39: 1322-1326 (Pubitemid 26389548)
-
(1996)
Diseases of the Colon and Rectum
, vol.39
, Issue.11
, pp. 1322-1326
-
-
Marcus, V.A.1
Viloria, J.2
Owen, D.3
Tsao, M.-S.4
-
4
-
-
0032713362
-
Malignant rhabdoid tumor of the colon: Report of a case
-
DOI 10.1007/s005950050649
-
Nakamura I, Nakano K, Nakayama K, et al. Malignant rhabdoid tumor of the colon: report of a case. Surg Today. 1999 ; 29: 1083-1087 (Pubitemid 29512615)
-
(1999)
Surgery Today
, vol.29
, Issue.10
, pp. 1083-1087
-
-
Nakamura, I.1
Nakano, K.2
Nakayama, K.3
Ishii, Y.4
Ohta, K.5
Takahashi, M.6
Yamada, T.7
Yamaguchi, K.8
Sakuma, H.9
Tsuchiya, A.10
Takenoshita, S.11
-
5
-
-
0028228789
-
Malignant rhabdoid tumour of the colon
-
Yang AH, Chen WYK, Chiang H. Malignant rhabdoid tumour of the colon. Histopatholgy. 1994 ; 24: 89-91
-
(1994)
Histopatholgy
, vol.24
, pp. 89-91
-
-
Yang, A.H.1
Wyk, C.2
Chiang, H.3
-
6
-
-
79959337448
-
A novel case of rhabdoid colon carcinoma associated with a CpG island methylator phenotype-positive phenotype and BRAF mutation
-
Pancione M, Di Blasi A, Sabatino L, et al. A novel case of rhabdoid colon carcinoma associated with a CpG island methylator phenotype-positive phenotype and BRAF mutation. Hum Pathol. 2011 ; 42: 1047-1052
-
(2011)
Hum Pathol
, vol.42
, pp. 1047-1052
-
-
Pancione, M.1
Di Blasi, A.2
Sabatino, L.3
-
8
-
-
0029165893
-
Malignant rhabdoid tumors: A clinicopathologic review and conceptual discussion
-
Wick MR, Ritter JH, Dehner LP. Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion. Semin Diagn Pathol. 1995 ; 12: 233-248
-
(1995)
Semin Diagn Pathol
, vol.12
, pp. 233-248
-
-
Wick, M.R.1
Ritter, J.H.2
Dehner, L.P.3
-
9
-
-
1642535480
-
BRAF Mutation Is Frequently Present in Sporadic Colorectal Cancer with Methylated hMLH1, but Not in Hereditary Nonpolyposis Colorectal Cancer
-
DOI 10.1158/1078-0432.CCR-1118-3
-
Deng G, Bell I, Crawley S, et al. BRAF mutation is frequently present 359 in sporadic colorectal cancer with methylated hMLH1, but not in 360 hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004 ; 10 (1). 191-195 (Pubitemid 38114179)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.1
, pp. 191-195
-
-
Deng, G.1
Bell, I.2
Crawley, S.3
Gum, J.4
Terdiman, J.P.5
Allen, B.A.6
Truta, B.7
Sleisenger, M.H.8
Kim, Y.S.9
-
10
-
-
58149147370
-
Colon cancer: It's CIN or CIMP
-
Issa JP. Colon cancer: It's CIN or CIMP. Clin Cancer Res. 2008 ; 14: 5939-5940
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5939-5940
-
-
Issa, J.P.1
-
11
-
-
54449092791
-
CpG island methylator phenotype in 349 colorectal cancers: Comparison of the new and classic CpG island 350 methylator phenotype marker panels
-
Lee S, Cho NY, Yoo EJ, Kim JH, Kang GH. CpG island methylator phenotype in 349 colorectal cancers: comparison of the new and classic CpG island 350 methylator phenotype marker panels. Arch Pathol Lab Med. 2008 ; 132: 1657-1665
-
(2008)
Arch Pathol Lab Med
, vol.132
, pp. 1657-1665
-
-
Lee, S.1
Cho, N.Y.2
Yoo, E.J.3
Kim, J.H.4
Kang, G.H.5
-
12
-
-
77954346705
-
Clinical practice guidelines. Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
-
Van Cutsem E, Nordlinger B, Cervantes A. Clinical practice guidelines. Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. Ann Oncol. 2010 ; 21 (suppl 5). v93 - v97
-
(2010)
Ann Oncol
, vol.21
, Issue.SUPPL. 5
-
-
Van Cutsem, E.1
Nordlinger, B.2
Cervantes, A.3
-
13
-
-
54249098184
-
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: Proposal for a European quality assurance program
-
van Krieken JH, Jung A, Kirchner T, et al. KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for a European quality assurance program. Virchows Arch. 2008 ; 453: 417-431
-
(2008)
Virchows Arch
, vol.453
, pp. 417-431
-
-
Van Krieken, J.H.1
Jung, A.2
Kirchner, T.3
|